1. Healthcare utilization and cost of pneumococcal disease in the United States;Vaccine,2011
2. Improving influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among adults aged <65 years at high risk: a report on recommendations of the Task Force on Community Preventive Services;MMWR Recomm Rep,2005
3. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP);MMWR Morb Mortal Wkly Rep,2012
4. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP);MMWR Morb Mortal Wkly Rep,2014
5. Pneumococcal vaccination remains a high priority;Infect Dis Clin Pract,2016